Literature DB >> 10713712

Cytoplasmic domain mutants of beta1 integrin, expressed in beta 1-knockout lymphoma cells, have distinct effects on adhesion, invasion and metastasis.

P J Stroeken1, E A van Rijthoven, E Boer, D Geerts, E Roos.   

Abstract

Structural requirements for beta 1 integrin cytoplasmic domain functions in adhesion, migration and signaling have been studied mainly for fibroblasts in vitro. The relevance for beta 1-dependent in vivo migration of lymphoid cells has not been assessed. To study this, we transfected beta 1 mutants into beta 1-deficient double knockout (DKO) ESb lymphoma cells, and tested the capacity of the cells to metastasize to liver and spleen. This was compared to alpha 4 beta 1-dependent invasion into cell monolayers in vitro and Mn2+-induced adhesion to fibronectin. Deletion of the five C-terminal residues or mutation of both threonines T788 and T789 to alanines blocked invasion and metastasis and greatly reduced adhesion, in line with known in vitro effects. However, mutations of the NPXY motif tyrosines had unexpected consequences. A Y783F mutation had no effect at all, but a Y783,795F double mutation strongly reduced Mn2+-induced adhesion, whereas it had limited effects on invasion and metastasis. Furthermore, cells expressing a beta 1 beta 2 chimeric subunit, which contains phenylalanines in the NPXY/F motifs, adhered poorly but invasion and metastasis was fully restored to the same levels as for cells expressing wild-type beta 1. We conclude that part of the functions of the beta 1 cytoplasmic domain that are required for adhesion are not essential for beta 1-dependent invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713712     DOI: 10.1038/sj.onc.1203423

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray.

Authors:  S Li; D T Ross; M E Kadin; P O Brown; M A Wasik
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Increased extracellular pressure enhances cancer cell integrin-binding affinity through phosphorylation of beta1-integrin at threonine 788/789.

Authors:  David H Craig; Christopher P Gayer; Keri L Schaubert; Yanzhang Wei; Jinhua Li; Yasmina Laouar; Marc D Basson
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-12       Impact factor: 4.249

3.  β1 integrin mediates colorectal cancer cell proliferation and migration through regulation of the Hedgehog pathway.

Authors:  Jia Song; Jixiang Zhang; Jing Wang; Jun Wang; Xufeng Guo; Weiguo Dong
Journal:  Tumour Biol       Date:  2014-11-12

4.  Disruption of C-terminal cytoplasmic domain of betaPS integrin subunit has dominant negative properties in developing Drosophila.

Authors:  Alison L Jannuzi; Thomas A Bunch; Marc C Brabant; Steven W Miller; Leona Mukai; Michael Zavortink; Danny L Brower
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

5.  β1A integrin is a master regulator of invadosome organization and function.

Authors:  Olivier Destaing; Emmanuelle Planus; Daniel Bouvard; Christiane Oddou; Cedric Badowski; Valentine Bossy; Aurelia Raducanu; Bertrand Fourcade; Corinne Albiges-Rizo; Marc R Block
Journal:  Mol Biol Cell       Date:  2010-10-06       Impact factor: 4.138

6.  beta(1)-integrin mediates pressure-stimulated phagocytosis.

Authors:  Sean Bhalla; Hiroe Shiratsuchi; David H Craig; Marc D Basson
Journal:  Am J Surg       Date:  2009-11       Impact factor: 2.565

7.  Two distinct cytoplasmic regions of the beta2 integrin chain regulate RhoA function during phagocytosis.

Authors:  Agnès Wiedemann; Jayesh C Patel; Jenson Lim; Andy Tsun; Yvette van Kooyk; Emmanuelle Caron
Journal:  J Cell Biol       Date:  2006-03-27       Impact factor: 10.539

8.  The linkage between beta1 integrin and the actin cytoskeleton is differentially regulated by tyrosine and serine/threonine phosphorylation of beta1 integrin in normal and cancerous human breast cells.

Authors:  K Takahashi
Journal:  BMC Cell Biol       Date:  2001-11-08       Impact factor: 4.241

9.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10

10.  Regulation of trophoblast beta1-integrin expression by contact with endothelial cells.

Authors:  Twanda L Thirkill; Sonia R Hendren; Arlen Soghomonians; Natalie F Mariano; Abdul I Barakat; Gordon C Douglas
Journal:  Cell Commun Signal       Date:  2004-06-09       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.